Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Addex shares are listed on the SIX Swiss Exchange and American Depositary Shares representing its shares are listed on the NASDAQ Capital Market, and trade under the ticker symbol "ADXN” on each ...
POET Technologies Inc. ('POET” or the 'Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets ...
Revenue and profit within guidance as reportedA record-high second quarter $258M in cash flow from operations, $242M in adjusted free cash flow iX Suite deals up 400% year over year NEWARK, Calif., Ju ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results